Jones Financial Companies
TARS icon

Jones Financial Companies’s Tarsus Pharmaceuticals TARS Stock Holding History

Jones Financial Companies’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
6,083
+927
+18% +$59.2K ﹤0.01% 2325
2026
Q1 		$342K Buy
5,156
+4,809
+1,386% +$336K ﹤0.01% 2208
2025
Q4 		$28.4K Buy
347
+49
+16% +$3.66K ﹤0.01% 2789
2025
Q3 		$16.8K Buy
298
+263
+751% +$12.9K ﹤0.01% 2883
2025
Q2 		$1.41K Buy
+35
New +$1.57K ﹤0.01% 3573

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jones Financial Companies's TARS Position: Q2 2026 in Review

Jones Financial Companies increased its Tarsus Pharmaceuticals (TARS) stake by 18% in Q2 2026, buying an estimated $59.2K and bringing the position to 6,083 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #2325.

Jones Financial Companies first reported a position in TARS in Q2 2025 and has held it in 5 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Jones Financial Companies held 6,083 shares of Tarsus Pharmaceuticals worth $383K as of Q2 2026.
  • Jones Financial Companies bought 927 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $59.2K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2325 holding.
  • Jones Financial Companies first reported a position in Tarsus Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.